Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iberogast in Functional Dyspepsia with Reflux Symptoms
NCT04059900Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iberogast in functional dyspepsia (FD), sponsored by Bayer. Started Jun 2009; status: completed.
02
Drugs
Iberogast
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT04059900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059900.